S
Stephanie Robu
Researcher at Technische Universität München
Publications - 12
Citations - 645
Stephanie Robu is an academic researcher from Technische Universität München. The author has contributed to research in topics: Biodistribution & Biochemical recurrence. The author has an hindex of 6, co-authored 12 publications receiving 364 citations.
Papers
More filters
Journal ArticleDOI
99mTechnetium-based Prostate-specific Membrane Antigen-radioguided Surgery in Recurrent Prostate Cancer.
Tobias Maurer,Tobias Maurer,Stephanie Robu,Margret Schottelius,Kristina Schwamborn,Isabel Rauscher,Nynke S. van den Berg,Nynke S. van den Berg,Fijs W. B. van Leeuwen,Bernhard Haller,Thomas Horn,Matthias Heck,Jürgen E. Gschwend,Markus Schwaiger,Hans-Jürgen Wester,Matthias Eiber +15 more
TL;DR: As a new technique for surgical guidance, 99mTc-PSMA-RGS is feasible, and has been proved to be of high value for successful intraoperative detection and removal of metastatic lesions in PC patients scheduled for salvage surgery.
Journal ArticleDOI
Preclinical evaluation and first patient application of 99mTc-PSMA-I&S for SPECT imaging and radioguided surgery in prostate cancer
Stephanie Robu,Margret Schottelius,Matthias Eiber,Tobias Maurer,Jürgen E. Gschwend,Markus Schwaiger,Hans-Jürgen Wester +6 more
TL;DR: In exemplary PCa patients, a relatively slow whole-body clearance of 99mTc-PSMA-I&S was observed due to high plasma protein binding of the tracer, but initial patient data indicate its comparable or even superior performance as a probe for PSMA-targeted RGS and also hint toward the unexpected potential of 99MTc/sub-KuE.
Journal ArticleDOI
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04.
Zohreh Varasteh,Sarajo Mohanta,Stephanie Robu,Miriam Braeuer,Yuanfang Li,Negar Omidvari,Geoffrey J. Topping,Ting Sun,Stephan G. Nekolla,Antonia Richter,Christian Weber,Andreas J. R. Habenicht,Uwe Haberkorn,Wolfgang A. Weber +13 more
TL;DR: 68Ga-FAPI-04 represents a promising radiotracer for in vivo imaging of post-MI fibroblast activation and may have significant diagnostic and prognostic value, which could aid clinical management of patients after MI.
Journal ArticleDOI
Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer
Thomas Horn,Markus Krönke,Isabel Rauscher,Bernhard Haller,Stephanie Robu,Hans-Jürgen Wester,Margret Schottelius,Fijs W. B. van Leeuwen,Henk G. van der Poel,Matthias Heck,Jürgen E. Gschwend,Wolfgang A. Weber,Matthias Eiber,Tobias Maurer +13 more
TL;DR: Prostate-specific membrane antigen radioguided surgery delays disease progression in selected patients with recurrent prostate cancer after radical prostatectomy and leads to a remarkable interval of biochemical recurrence-free survival in a subset of patients.
Journal ArticleDOI
Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007
Stephanie Robu,Alexander Schmidt,Matthias Eiber,Margret Schottelius,Thomas Günther,Behrooz H. Yousefi,Markus Schwaiger,Hans-Jürgen Wester +7 more
TL;DR: Both 18F-labeled EuE-based PSMA ligands showed excellent in vitro and in vivo PSMA-targeting characteristics and the substantially higher tumor accumulation in mice suggests their high value for preclinical studies investigating the effects on PSma-expression.